BioVinc
PrivateLast Round
Grant
Mar 3, 2023
Total Funding Raised
$7.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BioVinc operates in Healthcare & Life Sciences and is based in Pasadena, California. Its latest recorded funding round was a Grant round in March 2023.
BioVinc is a biotechnology company that develops bone-targeted therapeutics and diagnostic molecular probes for the treatment of bone diseases and infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioVinc Comparables
Compare BioVinc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MBC Pharma, Inc. | 92% | |
| Atlanthera | 90% | |
| Mesentech Inc. | 85% |
For institutional investors. Book with your work email.
BioVinc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 3, 2023 | ||||
| Grant | Aug 21, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioVinc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| NIH RADx | Grant |
| National Institute of Dental and Craniofacial Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 184% MoM, reaching 1.4K.
- Apr 6, 2026
Monthly visitors increased 59% MoM.
For institutional investors. Book with your work email.
BioVinc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioVinc's valuation, stock price, and market status.
Is BioVinc a public or private company?
BioVinc is a private company.
What is the current stock price of BioVinc?
BioVinc is a private company, so its shares have no public market price. Caplight tracks BioVinc's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioVinc worth (valuation)?
Valuation information for BioVinc is not publicly available.
Can I buy BioVinc stock?
BioVinc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioVinc's last funding round?
BioVinc's most recent funding round was Grant on March 3, 2023.
Who are the main investors in BioVinc?
Key investors in BioVinc include National Institute of Allergy and Infectious Diseases, NIH RADx, National Institute of Dental and Craniofacial Research.
Will BioVinc IPO soon?
No public IPO plans have been announced for BioVinc.
How can I track BioVinc secondary market activity?
Caplight tracks bids, offers, and trades in BioVinc's shares on secondary markets.